Loading...
Loading...
In the last 30 days, the company did not witness any estimate revisions and the Zacks Consensus Estimate also remained unchanged. Friday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Raptor Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Other better-ranked stocks in the med-drugs industry include Actelion Ltd. (ALIOF), Cambrex Corporation. CBM and Curis, Inc. CRIS. All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
RAPTOR PHARMACT RPTP: Free Stock Analysis Report
CAMBREX CORP CBM: Free Stock Analysis Report
CURIS INC CRIS: Free Stock Analysis Report
ACTELION LTD (ALIOF): Get Free Report
To read this article on Zacks.com click here.
Zacks Investment Research
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: Movers & ShakersGeneral
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in